Luc Hessel
Overview
Explore the profile of Luc Hessel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barker L, Hessel L, Walker B
Tuberculosis (Edinb)
. 2012 Mar;
92 Suppl 1:S25-9.
PMID: 22441156
A rational process is clearly needed and can be extremely helpful for selection, assessing and advancing TB vaccine candidates from entry into preclinical and clinical development and for advancing candidates...
2.
Hessel L
Influenza Other Respir Viruses
. 2009 Jul;
3(4):165-70.
PMID: 19627373
An influenza pandemic will place an enormous strain on the world's vaccine production, distribution and administration systems. Following a pandemic declaration, industry's priority will be to deliver as much vaccine...
3.
Hehme N, Colegate T, Palache B, Hessel L
Vaccine
. 2009 Feb;
26 Suppl 4:D23-6.
PMID: 19230154
Influenza represents a public health paradox. The virus is responsible for significant death, disease and economic loss. However, despite the availability of safe and efficacious vaccines, uptake is poor. While...
4.
5.
Brabin L, Greenberg D, Hessel L, Hyer R, Ivanoff B, Van Damme P
Vaccine
. 2008 Jul;
26(33):4120-34.
PMID: 18617295
Based on the December 2006 Fondation Mérieux International Scientific Symposium, the current state of adolescent immunization is reviewed with a focus on the policy and programmatic issues that impact the...
6.
Barry S, Hessel L, Gualde N
Can Bull Med Hist
. 2008 May;
24(2):445-66.
PMID: 18447314
Influenza remains a serious disease in humans and animals (primarily poultry). Since influenza is caused by a virus that both undergoes continuous antigenic change and possesses an animal reservoir, it...
7.
Hessel L, Guenaneche F, Biasio L, Di Marzo R
Vaccine
. 2007 Apr;
25(14):2539-40.
PMID: 17465039
No abstract available.
8.
Lagos R, Hoffenbach A, Scemama M, Dupuy M, Schodel F, Hessel L, et al.
Hum Vaccin
. 2006 Oct;
1(3):112-7.
PMID: 17012870
Objectives: To assess the safety, immunogenicity and lot consistency of a liquid hexavalent combined vaccine (DTaP-IPV-PRP approximately T-HBs, HEXAVAC) (Sanofi-Pasteur MSD, France) administered to infants at two, four and six...
9.
Gustafsson L, Hessel L, Storsaeter J, Olin P
Pediatrics
. 2006 Sep;
118(3):978-84.
PMID: 16950988
Objectives: The purpose of this work was to evaluate the long-term effectiveness of vaccination with acellular pertussis vaccines at 3, 5, and 12 months of age. Methods: Clinical follow-up of...
10.
Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt H, von Kries R
Pediatr Infect Dis J
. 2006 May;
25(6):507-12.
PMID: 16732148
Background: In Germany, Haemophilus influenzae type b (Hib), polio and hepatitis B (HBV) vaccines have been combined with diphtheria, tetanus and acellular pertussis vaccines. We examined whether the use of...